Skip to main content
. 2022 Feb 13;17:11. doi: 10.1186/s13017-022-00414-2

Table 2.

Comparison of characteristics of patients between the two groups (TAC versus partial colectomy) after propensity matching

Variable All Patients, n = 186 Total Abdominal Colectomy, n = 93 Partial Colectomy, n = 93 P-Value
Age (years), Median [Q1-Q3] 65 [57–75] 66 [55 –75] 0.71
Gender 0.755
 Female 91 (48.9) 47 (50.5) 44 (47.3)
 Male 95 (51.1) 46 (49.5) 49 (52.7)
Admitted from NA
 From acute care hospital inpatient 33 (17.7) 20 (21.5) 13 (14)
 Not transferred (admitted from home) 111 (59.7) 51 (54.8) 60 (64.5)
 Nursing home—Chronic care—Intermediate care 25 (13.4) 11 (11.8) 14 (15.1)
 Outside emergency department 10 (5.4) 5 (5.4) 5 (5.4)
 Transfer from other 5 (2.7) 4 (4.3) 1 (1.1)
 Unknown 2 (1.1) 2 (2.2) 0 (0)
Race, white, n (%) 140 (75.3) 68 (73.1) 72 (77.4) 0.596
Sepsis statusa, n (%) 0.956
 None 13 (7) 6 (6.5) 7 (7.5)
 Sepsis 60 (32.3) 29 (31.2) 31 (33.3)
 Septic Shock 101 (54.3) 52 (55.9) 49 (52.7)
 SIRS 12 (6.5) 6 (6.5) 6 (6.5)
WBC count, 109/L, n (%) NA
 4–11.9 45 (24.2) 20 (21.5) 25 (26.9)
 12–19.9 43 (23.1) 15 (16.1) 28 (30.1)
 20–34.9 37 (19.9) 23 (24.7) 14 (15.1)
 35–44.9 11 (5.9) 7 (7.5) 4 (4.3)
 ≥ 45 15 (8.1) 5 (5.4) 10 (10.8)
 < 4 19 (10.2) 9 (9.7) 10 (10.8)
 Unknown 16 (8.6) 14 (15.1) 2 (2.2)
Diabetes, n (%) 0.878
 INSULIN 28 (15.1) 15 (16.1) 13 (14)
 NO 149 (80.1) 74 (79.6) 75 (80.6)
 NON-INSULIN 9 (4.8) 4 (4.3) 5 (5.4)
Smoking, n (%) 0.86
 No 142 (76.3) 72 (77.4) 70 (75.3)
 Yes 44 (23.7) 21 (22.6) 23 (24.7)
Ventilator dependencya, n (%) 0.268
 No 124 (66.7) 58 (62.4) 66 (71)
 Yes 62 (33.3) 35 (37.6) 27 (29)
COPD, n (%) 0.458
 No 153 (82.3) 79 (84.9) 74 (79.6)
 Yes 33 (17.7) 14 (15.1) 19 (20.4)
Ascites, n (%) 0.831
 No 162 (87.1) 80 (86) 82 (88.2)
 Yes 24 (12.9) 13 (14) 11 (11.8)
CHF, n (%)  > 0.99
 No 169 (90.9) 84 (90.3) 85 (91.4)
 Yes 17 (9.1) 9 (9.7) 8 (8.6)
HTN, n (%) 0.551
 No 71 (38.2) 33 (35.5) 38 (40.9)
 Yes 115 (61.8) 60 (64.5) 55 (59.1)
CRF, n (%)  > 0.99
 No 160 (86) 80 (86) 80 (86)
 Yes 26 (14) 13 (14) 13 (14)
CRF on dialysis, n (%) 0.838
 No 160 (86) 79 (84.9) 81 (87.1)
 Yes 26 (14) 14 (15.1) 12 (12.9)
Disseminated Cancer, n (%)  > 0.99
 No 157 (84.4) 79 (84.9) 78 (83.9)
 Yes 29 (15.6) 14 (15.1) 15 (16.1)
Steroid, n (%) 0.814
 No 164 (88.2) 83 (89.2) 81 (87.1)
 Yes 22 (11.8) 10 (10.8) 12 (12.9)
Weight loss 0.752
 No 176 (94.6) 89 (95.7) 87 (93.5)
 Yes 10 (5.4) 4 (4.3) 6 (6.5)
Coagulopathy, n (%)  > 0.99
 No 152 (81.7) 76 (81.7) 76 (81.7)
 Yes 34 (18.3) 17 (18.3) 17 (18.3)
Blood transfusiona, n (%) 0.789
 No 168 (90.3) 83 (89.2) 85 (91.4)
 Yes 18 (9.7) 10 (10.8) 8 (8.6)
Wound class, n (%) NA
 1-Clean 2 (1.1) 0 (0) 2 (2.2)
 2-Clean/Contaminated 29 (15.6) 20 (21.5) 9 (9.7)
 3-Contaminated 56 (30.1) 31 (33.3) 25 (26.9)
 4-Dirty/Infected 99 (53.2) 42 (45.2) 57 (61.3)
ASA class, n (%) NA
 2-Mild Disturb 5 (2.7) 2 (2.2) 3 (3.2)
 3-Severe Disturb 33 (17.7) 14 (15.1) 19 (20.4)
 4-Life Threat 112 (60.2) 57 (61.3) 55 (59.1)
 5-Moribund 35 (18.8) 20 (21.5) 15 (16.1)
 None assigned 1 (0.5) 0 (0) 1 (1.1)

ASA; American Society of Anesthesiology, CHF; Congestive heart failure, CRF; chronic renal failure,

COPD; chronic obstructive pulmonary disease, Q1-Q3; first quartile-third quartile,  interquartile range (IQR), SIRS; systemic inflammatory response syndrome. WBCs; White blood cell counts

aPrior to surgery

n; number of patients, %; percentage

NA; not applicable